Apomorphine HCl CAS: 41372-20-7 Apomorphine HCl is a versatile API commonly associated with treating Parkinson’s disease. When those who suffer from Parkinson’s have difficulty walking or speaking, they can take apomorphine as a means to gain control over their movements. It can’t prevent the episodes, but it can make it easier to handle the symptoms[…]
Apomorphine HCl: A Promising Drug to Help Parkinson’s Patients
Anti-Parkinsons Tags: Apomorphine Nov 14, 2018
Joseph Gelfand Joins LGM Pharma as VP of Supply Chain and Sales Operations
LGM Pharma, Press Release Tags: Joseph Gelfand Nov 12, 2018
ERLANGER, Kentucky / BOCA RATON, Florida — LGM Pharma, an innovation-driven active pharmaceutical ingredient (API) company, headquartered in Erlanger, Kentucky with offices in Florida, New Jersey and Israel recently announced the appointment of Mr. Joseph Gelfand as Vice President of Supply Chain and Sales Operations at the Boca Raton, Florida location. In this capacity, Mr.[…]
A Controversial API with Plenty of Promise: Naltrexone
Anti-Obesity Product, Chemotherapeutic / Anti-Neoplastic, Drug Research & Development API Tags: Obesity Sep 14, 2018
Naltrexone is typically administered to those who have a history of substance abuse, namely opiates or alcohol. The drug works to block the intensity of the drugs, so people are less likely to associate them with euphoria or pain relief. Because drug use in this country is still so stigmatized, it’s difficult to separate public[…]
Octreotide Acetate: Managing Growth-Release Hormones to Reduce Symptoms and Promote Balance
Hormonal Agent Tags: acromegalygrowth hormone Aug 27, 2018
Octreotide Acetate CAS #: 79517-01-04 Octreotide Acetate is prescribed for a variety of GI issues, mainly for severe diarrhea brought upon by carcinoid symptoms. Its designed to imitate the natural growth-hormone inhibitor in the body, which makes it easier for the endocrine system to do its job. This API limits the excess release of glucagon secretion and insulin, making[…]
How Fingolimod Hydrochloride Limits MS Relapses in Children and Adults
Drug Research & Development API, Immunosuppressant Jul 31, 2018
Fingolimod Hydrochloride CAS: 162359-56-0 Fingolimod Hydrochloride is typically given to those who suffer from multiple sclerosis (MS) relapses. It doesn’t eliminate episodes in the body entirely, but it can reduce them by 50% or more over the course of several years. When the body is having an autoimmune reaction, the lymphocytes play a big role[…]
Amphotericin B: A Serious and Effective Treatment for Extreme Fungal Infections
Anti-Fungal, Drug Research & Development API Tags: Amphotericin B Jul 25, 2018
Amphotericin B: CAS No: 1397-89-3 Amphotericin B is an API used to treat a number of fungal infections. This pharmaceutical ingredient is aggressive when interacting with the fungus which is why it’s generally used for serious cases only. However, it’s also proven itself to be one of the most effective ways to stop the spread[…]
Sitagliptin Phosphate: A Blockbuster DPP-4 Inhibitor for Treating Type-2 Diabetes
Anti-Diabetic, Drug Research & Development API Tags: diabetes Jul 11, 2018
Sitagliptin Phosphate CAS No: 654671-78-0 Sitagliptin Phosphate was approved more than a decade ago primarily as a way to combat type 2 diabetes. This dipeptidyl-peptidase-4 inhibitor lowers the levels of glucose in the patient directly following a meal and can also help regulate general blood sugar levels over time. It’s usually used in combination with[…]
Brimonidine Tartrate a Safe and Effective API for Reducing Pressure Behind the Eye
Drug Research & Development API Tags: glaucomalatanoprost Jul 09, 2018
Brimonidine Tartrate CAS No: 79570-19-7 Known for treating open-angle glaucoma, brimonidine tartrate is a safe and effective API for reducing pressure behind the eye. The medication allows better drainage of fluids to both relieve patient suffering and protect eyes from further damage. High-fluid pressure can cause anything from mild nerve damage to total blindness. However,[…]
The U.S. Centers for Disease Control recently released a report that opioid-related overdoses have increased at a rate of 30% between 2016 and 2017. As the nation struggles to decide the best way to combat this epidemic, APIs like naloxone can be a light in the dark when it comes to reducing the damage done[…]
ERLANGER, Kentucky / BOCA RATON, Florida – LGM Pharma, an innovation-driven active pharmaceutical ingredient (API) company, headquartered in Erlanger, Kentucky with offices in Florida, New Jersey and Israel recently announced the appointment of Mr. Keith Lavery as chief financial officer (CFO) reporting to Dr. Prasad Raje, the CEO for LGM Pharma. In this capacity, Mr.[…]